Clinical Trials Logo

Clinical Trial Summary

This is a phase 1, safety and PK Open-Label trial evaluating the plasma, epithelial lining fluid, and alveolar macrophage concentrations of intravenous Minocin® (Minocycline) for injection in healthy adult subjects.


Clinical Trial Description

The purpose of this study is to evaluate the safety of Minocin IV and measure plasma, epithelial lining fluid, and alveolar macrophage drug levels after six doses of Minocin IV given 12 hours apart, administered as 1-hour infusions in healthy adult subjects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03291158
Study type Interventional
Source Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Contact
Status Withdrawn
Phase Phase 1
Start date April 2018
Completion date December 2018

See also
  Status Clinical Trial Phase
Completed NCT05019950 - Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers Phase 1
Completed NCT01366339 - Tolerance and Pharmacokinetics Study of MNTX Tablets Phase 1
Completed NCT01862835 - Impact of Estradiol Addback Phase 1
Completed NCT01629446 - Lofexidine Mass Balance in Volunteers Phase 1
Completed NCT02026973 - Impact of Endogenous E2 on SSI and GH Rebound Phase 1
Completed NCT03860571 - Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers Phase 1
Recruiting NCT03234504 - Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display
Completed NCT04188730 - A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution Phase 1
Completed NCT02271282 - Estradiol-Receptor Blockade in Older Men and Women Phase 1
Completed NCT02802631 - Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults Phase 1